Coronavirus: Pfizer vaccine effective against 16 mutations found in variants, preliminary study says

The Pfizer-BioNTech COVID-19 vaccine appears to be effective against 16 mutations found in new coronavirus variants, according to preliminary data from a study.

>> Read more trending news

The Associated Press is reporting that the study, conducted by Pfizer and University of Texas researchers, found that the vaccine appeared to work against N501Y, a mutation found in new variants from the United Kingdom and South Africa, in lab tests, the AP reported.

The study, which has not yet been peer-reviewed, also found that the vaccine seemed to protect against 15 other mutations, according to the AP. However, researchers have not yet tested the vaccine’s effectiveness against E484K, an additional mutation found in one of the South African variants, the news agency reported.

>> Read the study here

Read more here.

– The Associated Press contributed to this report.

1 of 11

Photos: First Americans vaccinated against COVID-19 receive second dose Registered Nurse (RN) Sandra Lindsay receives a second dose of the Pfizer-BioNTech COVID-19 vaccine at Long Island Jewish Medical Center in the Queens borough of New York, U.S., on Monday, Jan. 4, 2021. (Shannon Stapleton/Reuters/Bloomberg via Getty Images)

More coronavirus pandemic coverage:

>> Coronavirus: CDC acknowledges airborne transmission of COVID-19

>> Is it COVID-19, flu, cold or allergies? What is causing you to feel sick this year

>> Coronavirus: CDC updates guidance for COVID-19 testing

>> Dangerous hand sanitizer list up to more than 150 products, FDA announces

>> Wash your masks: How to clean a cloth face covering

>> Fact check: Will masks lower the oxygen level, raise the carbon dioxide in your blood?

>> How to not let coronavirus pandemic fatigue set in, battle back if it does

Cox Media Group